Event
European Drug Discovery Workshop 2025
📅 Date: July 3-4, 2025
📍 Location: Tubingen, Germany
Viviana Agus,
Unit Manager
Cell Biology | Assay Development
Let’s talk discovery at European Drug Discovery Workshop 2025
Axxam is heading to Reutlingen for the European Drug Discovery Workshop 2025!
Join us on July 3–4 at the NMI Natural and Medical Sciences Institute to explore the future of drug discovery—from novel screening technologies to cutting-edge cellular models.
This event brings together leading minds from biotech, pharma, and academia to exchange ideas, spark collaborations, and drive innovation in early-stage drug discovery. We’ll be there with fresh science, real-world case studies, and proven expertise.
What we’re presenting
Viviana Agus, our unit manager of cell biology, is contributing with two talks and one poster—all focused on next-generation screening strategies for complex targets and functional phenotyping.
🎤Talks
🔷Fluorescent tracers for electrogenic proteins: pick the right readout to untackle your target at FDSS‑EX
Get a glimpse into how high-sensitivity fluorescent tracers and smart readouts help reveal the function of electrogenic membrane proteins—right where biology meets technology
🔷 iPS cells: drug screening at the rhythm of calcium in cardiac and neuronal cells
Discover how we use iPSC-derived neurons and cardiomyocytes to monitor calcium signaling in real time—bringing functional data to life in safety and efficacy screening.
📌 Poster
Screening modalities for ion channels and transporters using optical plate readers
From throughput to selectivity: this poster walks through how optical platforms accelerate screening for ion channels and transporters with precision and scalability.
Why meet Axxam at EDDW?
If you’re working on:
Electrogenic proteins or ion channels
iPSC-based models for CNS or cardiac disease
High-content or optical screening platforms
…then we should talk.
👉 Schedule a meeting today and explore potential collaborations.
Discover more about our solution: Discovery Solutions | From target to lead